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Abstract
Objectives: The lack of consistent data on the effect internal mammary harvesting on pulmonary functions has triggered the
research group to answer the question using a prospective case control study.
Methods: This is a prospective study of 90 patients undergoing elective coronary artery bypass grafting operations (CABG), in the
Cardiothoracic Surgery departments at Basildon University Hospitals, UK & Ain Shams University hospitals between September
2009 till November 2015 (51& 39 patients respectively). The patients were divided into 3 groups based on the operative technique:
Group I: The saphenous vein grafts (SVG) were used for CABG operation (30 patients).
Group II: The left internal mammary artery (LIMA) graft was used only or with saphenous vein grafts for CABG operations
and the pleura was left intentionally intact (30 patients).
Group III: The LIMA graft was used only or with saphenous vein grafts for CABG operations and the pleura was opened (30
patients).
Results: When the 3 groups were compared together, it was found that, the mean values of Slow vital capacity (SVC), Forced vital
capacity (FVC), and Forced expiratory volume in first second (FEV1) of group I were: 58.750 ± 10.325, 57.993 ± 6.425, and
61.914 ± 8.912 respectively and those of group II were: 40.901 ± 5.361, 39.355 ± 5.278, and 43.242 ± 9.126 and group III are
31.779 ± 6.99, 32.602 ± 4.731 and 34.638 ± 5.799 respectively, with P < 0.001 denoting a highly significant decrease in group III
over group II & group I respectively.
Conclusion: CABG has a profound effect on pulmonary functions. The saphenous vein group showed the least reduction pul-
monary functions followed by those LIMA patients with intact pleura.
Copyright © 2016, The Egyptian Society of Cardio-thoracic Surgery. Publishing services by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Coronary artery bypass grafting (CABG) has become one of the most common operations and an important
therapeutic modality in the treatment of ischemic heart disease. Pulmonary complications have been described in
many studies following CABG [1e3]. One of the major pulmonary problems post CABG is reduction in lung
volumes which can be attributed to atelectasis, pleural effusions and phrenic palsy following internal mammary
artery (IMA) harvesting. Other studies on the other hand, have found that IMA harvesting with or without opening
the pleura has no effect on post op pulmonary complications [4]. Taking into consideration the paucity and
inconsistency of the available data with regards to harvesting of the IMA and the development of pulmonary
complications, the research team aimed to study the effect of IMA harvesting in coronary artery bypass grafting
operation on pulmonary function and arterial blood gases taking a cohort of patients who had CABG with SVG only
as a control group.2. Patients and method
This work is a prospective study of 90 patients of coronary artery disease, undergoing elective coronary artery
bypass grafting operations (CABG), in the Cardio-Thoracic Surgery department, Basildon university hospitals, UK&
Ain Shams University hospitals between September 2009 till November 2015 (51 & 39 patients respectively).
The patients were divided into 3 groups based on the operative technique:
Group I: In which, SVGs were used for CABG operation (30 patients).
Group II: In which, LIMA graft was used only or with SVGs for CABG operations and pleura was intentionally left
intact (30 patients).
Group III: In which, LIMA graft was used only or with SVGs for CABG operations and the pleura was opened (30
patients).
A) Preoperative laboratory investigations: were done to assess the condition of the patient before surgery. These
laboratory investigations included: complete blood picture (CBC), blood cholesterol, blood sugar, liver and
kidney function tests, and coagulation profile.
B) Pulmonary function tests: were done for all patients
▪ Preoperative
▪ Three weeks after the operation
These pulmonary function tests included
1. Slow vital capacity (SVC)
2. Forced vital capacity (FVC)
3. Forced expiratory volume in first second (FEV1).
4. Ratio between FEV1 and FVC.
These 4 functions were done for all patients using spirometry.
C) Arterial blood gases: Pre and post-operative arterial blood samples were withdrawn to assess partial pressure of O2
in arterial blood (PaO2), partial pressure of CO2 in arterial blood (PaCO2) and O2 saturation percent (O2 sat%).
We aimed to observe the effects of mammary graft harvesting on respiratory complications, therefore, any
concomitant disease that could affect the results became an exclusion criterion. Patients with chronic obstructive
pulmonary disease (COPD) or skeletal abnormalities that caused pulmonary restriction were excluded from the study.
Patients over 75 years of age were also not enrolled.
The choice of not harvesting IMA in patients who had veins only, was the consultant preference.
Patients in which SVGs were used for CABG operation and had one or both of the pleurae accidentally opened
were excluded.
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Data were collected, coded, and then analyzed using SPSS® version 12.0. Data were presented as mean and
standard deviation. Between groups analysis was performed by one way ANOVA or KruskaleWallis test as appro-
priate. Tukey HSD test and ManneWhitney test were used as post hoc tests whenever indicated. Within-group
analysis was done by paired t-test or Wilcoxon signed rank test as appropriate. Any difference with P-value < 0.05
was considered statistically significant.3. Results
3.1. Preoperative variables
Table 1.Table 1
Comparison between the three groups as regard preoperative variables.
Group I Group II Group III Chi-square
X2 P-value
Sex Male 23 20 19 1.348 0.510
76.67 66.67 63.33
Female 7 10 11
23.33 33.33 36.67
Age Range 45e73 47e70 49e75 F ¼ 0.981 0.782
Mean ± SD 51.64 ± 14.64 52.348 ± 14.556 50.465 ± 18.5466
Smoking N (%) 24 (80) 21 (70) 20 (66.67) 0.400 0.819
HTN N (%) 15 (50) 17 (56.67) 13 (43.33) 0.533 0.766
DM N (%) 9 (30) 12 (40) 10 (33.33) 0.452 0.798
Hypercho-lesterolemia N (%) 10 (33.33) 8 (26.67) 11 (36.67) 0.483 0.786
FH N (%) 13 (43.33) 15 (50) 13 (43.33) 2.951 0.86
Renal Impairment N (%) 3 (43.33) 2 (50) 4 (43.33) 0.741 0.690
ST changes N (%) 20 (66.67) 23 (76.67) 19 (63.33) 1.348 0.510
LV hypertrophy N (%) 8 (26.67) 11 (36.67) 9 (30) 0.726 0.696
Q-wave N (%) 6 (20) 4 (13.33) 5 (16.67) 0.480 0.787
Increased Cardiothoracic ratio N (%) 10 (33.33) 11 (36.67) 9 (30) 0.300 0.861
Prominent Aortic knuckle N (%) 3 (10) 2 (6.67) 4 (13.33) 0.741 0.690
LVD N (%) 10 (33.33) 9 (30) 8 (26.67) 0.317 0.853
Ventricular wall dyskinesia N (%) 7 (23.33) 5 (16.67) 8 (26.67) 0.900 0.638
HTN: hypertension, DM: diabetes mellitus, FH: family history of ischemic heart disease, P-value < 0.05 denotes significant difference, P-
value < 0.01 denotes a highly significant difference, P-value > 0.05 denotes a non significant difference. LVD: left ventricle dysfunction.3.2. Operative variables
Table 2.Table 2
Comparison between the three groups as regard ischemic time and cardiopulmonary bypass time (CPB: cardio-pulmonary bypass).
Group I Group II Group III ANOVA
F P-value
Ischemic time Range 29.4e60.73 32.43e50.33 28.78e57.04 1.67 0.194
Mean ± SD 44.805 ± 8.302 41.599 ± 4.191 43.255 ± 7.193
CPB time Range 54.41e161.95 52.98e129.95 55.70e141.78 0.703 0.498
Mean ± SD 106.550 ± 25.480 100.409 ± 16.900 105.086 ± 19.533
There was statistically non significant difference between the three groups as regard ischemic time and cardiopulmonary bypass time.
CPB: cardio-pulmonary bypass.
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Table 3.Table 3
Comparison between the three groups as regard postoperative course and complications.
Group I Group II Group III Chi-square
X2 P-value
Delayed extubation N (%) 2 (6.67) 1 (3.33) 3 (10) 1.071 0.585
Sternal wound infection N (%) 3 (10) 1 (3.33) 1 (3.33) 1.694 0.429
Leg wound infection N (%) 2 (6.67) 2 (6.67) 1 (3.33) 0.424 0.809
Chest infection N (%) 3 (10) 3 (10) 2 (6.67) 0.274 0.872
Postoperative bleeding N (%) 6 (20) 4 (13.37) 5 (16.67) 0.48 0.79
High inotropic support N (%) 3 (10) 2 (6.67) 4 (13.33) 0.74 0.69
There was statistically non significant difference between the three groups as regard postoperative course and complications.3.3.1. Preoperative and postoperative pulmonary function tests
Table 4.Table 4
Comparison between the pulmonary function tests of the three groups before and after the operation: a- SVC%, b- FVC%, c- FEV1%, and d- FEV1/
FVC%.
Before After Paired t-test
t P-value
a- SVC%
Group I Range 51.447e103.855 34.861e78.716 6.892 0.000
Mean ± SD 80.347 ± 12.827 58.750 ± 10.325
Group II Range 55.983e104.852 30.166e51.880 16.227 0.001*
Mean ± SD 85.010 ± 12.336 40.901 ± 5.361
Group III Range 55.297e98.454 12.541e41.668 19.652 0.001*
Mean ± SD 82.013 ± 10.825 31.779 ± 6.699
ANOVA f 1.158 93.991
P-value 0.319 0.001*
Tukey's test I&II 0.854 0.001*
I&III 0.295 0.001*
II&III 0.601 0.001*
b- FVC%
Group I Range 56.216e121.406 44.114e69.454 7.963 0.001*
Mean ± SD 80.748 ± 13.821 57.993 ± 6.425
Group II Range 45.179e111.943 29.941e49.048 16.554 0.001*
Mean ± SD 78.062 ± 11.874 39.355 ± 5.278
Group III Range 53.520e112.105 24.674e40.969 19.928 0.001*
Mean ± SD 81.593 ± 11.637 32.602 ± 4.731
ANOVA f 0.654 170.084
P-value 0.522 0.001*
Tukey's test I&II 0.963 0.001*
I&III 0.684 0.001*
II&III 0.519 0.001*
c- FEV1%
Group I Range 69.161e105.482 49.109e79.722 9.183 <0.001*
Mean ± SD 88.065 ± 9.685 61.914 ± 8.912
Group II Range 65.668e100.793 27.226e60.328 15.336 <0.001*
Mean ± SD 85.998 ± 9.294 43.242 ± 9.126
Group III Range 72.540e113.509 20.829e44.953 27.230 <0.001*
Mean ± SD 87.448 ± 9.299 34.638 ± 5.799
ANOVA f 0.380 89.129
P-value 0.685 <0.001*
Tukey's test I&II 0.965 <0.001*
I&III 0.674 <0.001*
II&III 0.823 <0.001*
Table 4 (continued )
Before After Paired t-test
t P-value
d- FEV1/FVC%
Group I Range 79.875e131.553 81.928e128.391 0.250 0.804
Mean ± SD 105.800 ± 14.362 104.905 ± 12.447
Group II Range 84.630e154.908 73.104e144.859 1.591 0.123
Mean ± SD 114.358 ± 16.779 109.035 ± 15.690
Group III Range 80.856e119.496 88.103e133.311 0.594 0.557
Mean ± SD 104.784 ± 9.620 106.686 ± 12.252
ANOVA f 1.289 0.700
P-value 0.117 0.499
SVC: slow vital capacity.
There was a statistically highly significant difference in SVC% before and after the operation for each group.
FVC: forced vital capacity.
There was a statistically highly significant difference in FVC% before and after the operation for each group.
FEV1: forced expiratory volume in 1 s.
There was a statistically highly significant difference in FEV1% before and after the operation for each group.
FEV1/FVC: forced expiratory volume in 1 s/forced vital capacity.
There was a statistically non significant difference in FEV1% before and after the operation for each group.
* statistically significant.
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were: 58.750 ± 10.325, 57.993 ± 6.425, and 61.914 ± 8.912 respectively and those of group II were: 40.901 ± 5.361,
39.355 ± 5.278, and 43.242 ± 9.126 and group III are 31.779 ± 6.99, 32.602 ± 4.731 and 34.638 ± 5.799 respectively,
with P < 0.001 denoting a highly significant decrease in group III over group II& group I respectively. FEV1/FVC of
group I is 104.905 ± 12.447 and that of group II is 109.035 ± 15.690 and that of group III is 106.686 ± 12.252 with
P < 0.05 indicating insignificant difference.3.3.2. Preoperative and postoperative arterial blood gases
Table 5.Table 5
Comparison between the three groups regarding preoperative and postoperative arterial blood gases: a- PO2, b- PCO2, and c- O2sat%.
Before After Paired t-test
t P-value
a- PO2
Group I Range 76.816e115.568 72.100e107.266 2.114 0.057
Mean ± SD 94.896 ± 8.316 89.738 ± 8.535
Group II Range 70.964e120.252 65.828e108.737 2.023 0.062
Mean ± SD 93.711 ± 11.137 87.436 ± 10.296
Group III Range 75.892e107.948 62.217e114.726 0.372 0.712
Mean ± SD 90.955 ± 9.061 89.693 ± 12.896
ANOVA f 1.336 0.452
P-value 0.268 0.638
b- PCO2
Group I Range 27.301e50.835 31.698e45.195 0.773 0.446
Mean ± SD 37.449 ± 5.376 38.428 ± 3.291
Group II Range 30.455e51.239 26.788e46.219 2.106 0.059
Mean ± SD 39.515 ± 4.461 37.006 ± 4.834
Group III Range 25.935e50.673 27.420e47.860 0.443 0.661
Mean ± SD 37.220 ± 5.375 36.615 ± 4.915
ANOVA f 1.850 1.404
P-value 0.163 0.251
(continued on next page)
Table 5 (continued )
Before After Paired t-test
t P-value
c- O2sat%
Group I Range 91.284e100.192 92.537e99.430 0.896 0.378
Mean ± SD 96.136 ± 1.993 95.614 ± 2.112
Group II Range 91.443e97.819 89.466e100.839 0.986 0.332
Mean ± SD 95.243 ± 1.739 95.707 ± 2.132
Group III Range 89.820e98.690 91.600e100.020 0.921 0.365
Mean ± SD 95.399 ± 2.095 94.980 ± 2.097
ANOVA f 1.795 1.052
P-value 0.172 0.354
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The three groups in this study showed a restrictive pattern. This is consistent with Shapira et al. (1990); in a
study performed on 29 patients, had shown that preoperatively FVC, FEV1 and FEF25e75% were significantly lower
than predicted values, which may represent an early COPD [5]. Ricardo et al. (2005), divided also their cases into 2
groups (saphenous group and mammary group), and they found that before operation there was no difference in
lung functions between the two groups but all values preoperatively were lower than predicted values [6].
Our data showed that CABG surgery was followed by a reduction in pulmonary functions. The 3 techniques
employed in this study were SVG and LIMA grafting with and without pleurotomy. The LIMA harvesting with pleu-
rotomy showed the greatest reduction in pulmonary function postoperatively, followed by LIMA harvesting with pleural
preservation, and SVC technique showed the least reduction. This restrictive pattern of functions could be explained by
the dissection of the chest wall needed for LIMA and the consequences of opening the pleura during LIMA harvesting.
Several results coincide with our results in showing that restrictive pulmonary impairment occurred after CABG
operations. Schuller et al. (2000); found a significant reduction in pulmonary function tests in patients having ster-
notomy for CABG with the saphenous vein used as a conduit [9]. Shapira et al. (1990); stated that postoperatively, a
restrictive pulmonary pattern affecting all lung functions was observed [5]. Wahl et al. (1996); found that the FVC
decreased dramatically in all groups during the first few postoperative days and was still reduced 1 week (study period)
after operation (P< 0.01). The FEV1/FVC ratio was not significantly changed in any group during the study period [8].
Ricardo et al. (2005); stated that lung functions in both groups were reduced on the second day (P < 0.001) and
remained below the pre-operative values for the duration of the study (4 days). The reduction was more pronounced in
the patients receiving an IMA graft [6]. Bonacchi et al. (2001) study showed that pleural integrity has a beneficial
effect on respiratory functional status after revascularization [7]. There are publications demonstrating that the
incidence of pleural effusion and atelectasis between the 2nd and 5th postoperative days is significantly higher in the
patients whose pleura was opened during surgery as compared to the patients whose pleura was not opened [10].
CABG operation is associated with several interventions that may alter pulmonary functions. Among these are
median sternotomy, establishment of extracorporeal circulation, deflating of the lungs during the ischemic period,
transfusion of blood, and in certain patients, the freeing up of the IMA pedicle by dissection from the chest wall. These
interventions may result in chest wall pain, tenderness, and stiffness, and increased extravascular lung water as well as
increased production and accumulation of secretions in the tracheo-bronchial tree [5].
Our arterial blood gases' results show that the blood gases were slightly more affected in group III over group II and
group I respectively. Ricardo et al. (2005) found that mean PaO2 was decreased after CABG operation [6], Also,
Shapira et al. (1990); found that both arterial oxygen and carbon dioxide tensions were significantly lower than the
preoperative values. These results were coinciding with our result in showing that the arterial blood gases also
decreased after CABG operation [5].
5. Conclusion
Improvement in surgical coronary bypass technique as well as the reduction in cardiopulmonary and general
anesthesia time has greatly reduced the perioperative morbidity and mortality due to pulmonary complications;
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least reduction followed by the group of LIMA graft with intact pleura.
6. Limitation of the study
Paucity of recent relevant references.
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